GLP-1 medications and PCOS

Polycystic ovary syndrome (PCOS) is one of the most common hormonal conditions affecting women of reproductive age. It is also one of the most frustrating when it comes to weight management. The hormonal imbalances that define PCOS — particularly insulin resistance — make losing weight significantly harder, even when you are doing everything right.

GLP-1 receptor agonist medications like Wegovy (semaglutide) and Zepbound (tirzepatide) are changing treatment options for women with PCOS. Not because they treat the condition directly, but because the weight loss they produce can have a meaningful downstream effect on nearly every symptom of the syndrome.

This guide explains what women with PCOS should know before starting GLP-1 treatment — including the potential benefits, the critical fertility considerations, and the nutrition strategies that can make the biggest difference.

PCOS and weight

PCOS is fundamentally a metabolic condition. While it manifests through reproductive symptoms — irregular periods, ovarian cysts, excess androgens — the underlying driver in most cases is insulin resistance. Your body produces insulin normally, but your cells do not respond to it efficiently. The result is elevated insulin levels, which trigger a cascade of hormonal imbalances.

This creates a frustrating cycle. Insulin resistance makes your body more likely to store fat, particularly around the midsection. That excess weight, in turn, worsens insulin resistance. The hormonal imbalance drives up androgen levels (testosterone and related hormones), which cause the symptoms most women associate with PCOS: acne, unwanted hair growth (hirsutism), thinning scalp hair, and irregular or absent periods.

The challenge, of course, is that PCOS makes weight loss harder than it is for women without the condition. Traditional approaches — calorie restriction and exercise alone — often produce limited results because they do not address the underlying insulin resistance that is driving weight gain. This is where GLP-1 medications enter the picture.

How GLP-1 medications may help

GLP-1 receptor agonists work by mimicking a hormone your body naturally produces after eating. They slow gastric emptying, reduce appetite, and — critically for women with PCOS — improve insulin sensitivity. This addresses the metabolic root of the condition, not just the symptoms.

When women with PCOS lose weight through GLP-1 treatment, the improvements often extend well beyond the number on the scale:

• Improved insulin sensitivity. As weight decreases, cells become more responsive to insulin. This reduces circulating insulin levels, which in turn reduces the hormonal signals that drive PCOS symptoms.
• Lower androgen levels. With improved insulin sensitivity, the ovaries produce fewer androgens. This can lead to visible improvements in acne, hirsutism, and hair thinning.
• More regular menstrual cycles. Many women with PCOS who lose weight through GLP-1 treatment report a return of regular, predictable periods — sometimes for the first time in years.
• Restored ovulation. Weight loss can restart ovulation in women whose cycles had become anovulatory. This has important implications for fertility, which we address in detail below.
• Reduced long-term metabolic risk. Women with PCOS have elevated rates of type 2 diabetes, heart disease, and metabolic syndrome. Weight loss through GLP-1 treatment addresses these risks directly.

Fertility implications

This is one of the most important sections of this article, and we want to be direct: if you have PCOS and start a GLP-1 medication, your fertility may improve. This is not a theoretical possibility — it is a documented outcome that requires proactive planning.

Many women with PCOS have been told they may have difficulty getting pregnant. Some have gone years without regular periods and have understandably assumed that pregnancy was unlikely without medical intervention. GLP-1-driven weight loss can change this picture quickly.

Here is what happens: as weight decreases and insulin sensitivity improves, the hormonal environment shifts. Androgen levels drop. The ovaries begin to function more normally. Ovulation — which may have been absent or irregular for years — can resume. And once ovulation resumes, pregnancy becomes possible.

Whether pregnancy is something you want now, want later, or want to avoid, this is a conversation you need to have with your clinician before starting GLP-1 treatment. At PEAK, we make this a standard part of the intake process for every reproductive-age woman.

Contraception considerations

If you are not planning to become pregnant, reliable contraception is essential while on GLP-1 treatment. This is true even if you have historically had irregular periods or have been told you may have difficulty conceiving.

There is an additional consideration specific to oral contraceptives: GLP-1 medications slow gastric emptying, which can affect the absorption of oral medications — including birth control pills. While this does not necessarily make the pill ineffective, it is a factor worth discussing with your clinician.

Options to discuss with your provider:

• Long-acting reversible contraceptives (LARCs). IUDs and implants are not affected by gastric emptying changes and provide highly reliable contraception. These are often the best option for women on GLP-1 medications.
• Injectable contraceptives. Depot medroxyprogesterone acetate (Depo-Provera) is not affected by oral absorption issues.
• Oral contraceptives. Still an option, but discuss with your clinician whether additional precautions are needed given the effects of GLP-1 medications on gastric emptying.
• Barrier methods. Condoms and other barrier methods can be used as a supplement to other contraception for additional protection during the early months of treatment when fertility changes may be most unpredictable.

When to stop for pregnancy planning

If you are planning to become pregnant, the timing of when to stop your GLP-1 medication is a critical conversation to have with your clinician. Current guidance is clear on this point.

This means pregnancy planning needs to be proactive, not reactive. If you think you may want to become pregnant within the next year, discuss this with your PEAK clinician before starting treatment. Together, you can develop a plan that includes:

• A target weight range to reach before transitioning off the medication
• A timeline for tapering and stopping the medication
• A nutrition and exercise plan to maintain weight loss during the washout period and through pregnancy
• Coordination with your OB-GYN or reproductive endocrinologist

The weight loss achieved during GLP-1 treatment can actually improve your chances of a healthy pregnancy. Women with PCOS who enter pregnancy at a lower weight have reduced risks of gestational diabetes, preeclampsia, and other pregnancy complications. The key is planning the transition carefully.

Which GLP-1 medication for PCOS?

Both Wegovy (semaglutide) and Zepbound (tirzepatide) can produce the degree of weight loss that improves PCOS symptoms. The choice between them is a clinical decision that depends on your individual profile, and your PEAK clinician will help you evaluate the options.

That said, there are some relevant differences worth understanding:

Wegovy (semaglutide 2.4mg)

Wegovy is a GLP-1 receptor agonist. It works by mimicking the GLP-1 hormone, reducing appetite, slowing gastric emptying, and improving insulin sensitivity. It has a well-established track record and extensive clinical trial data, including the SELECT cardiovascular outcomes trial.

Zepbound (tirzepatide)

Zepbound is a dual GLP-1/GIP receptor agonist. It acts on two incretin pathways rather than one, which may offer additional benefits for insulin sensitivity and glucose metabolism. In clinical trials, tirzepatide produced greater average weight loss than semaglutide, and its dual mechanism of action on insulin pathways may be particularly relevant for women with PCOS, where insulin resistance is a primary driver.

There is no universally “better” option. The best medication is the one that fits your metabolic profile, your insurance situation, and your treatment goals. This is a decision to make with your clinician, not based on marketing or social media.

Nutrition for PCOS on GLP-1

Nutrition for women with PCOS on GLP-1 treatment requires a more targeted approach than standard dietary guidance. The reduced appetite from GLP-1 medications makes every calorie count more — you are eating less overall, so what you eat needs to do more work for your body. At PEAK, our dietitian develops individualized plans that address both the GLP-1 treatment and the PCOS simultaneously.

Insulin-resistant diet modifications

Because insulin resistance is the metabolic core of PCOS, your nutrition plan should prioritize blood sugar stability. This means:

• Pairing carbohydrates with protein and healthy fats. Never eat carbohydrates alone. Combining them with protein and fat slows absorption and prevents the insulin spikes that worsen PCOS.
• Choosing low-glycemic carbohydrates. Whole grains, legumes, and non-starchy vegetables produce a more gradual insulin response than refined carbohydrates, white bread, or sugary foods.
• Prioritizing protein at every meal. Protein is essential on GLP-1 medications to preserve lean muscle mass during weight loss. For women with PCOS, it also helps stabilize blood sugar. Aim for 25–30 grams of protein per meal.
• Limiting added sugars and refined carbohydrates. These cause rapid insulin spikes that directly worsen the hormonal environment driving PCOS symptoms.

Anti-inflammatory foods

PCOS involves chronic low-grade inflammation, which compounds insulin resistance and worsens symptoms. Incorporating anti-inflammatory foods into your diet can help:

• Fatty fish. Salmon, sardines, and mackerel provide omega-3 fatty acids with documented anti-inflammatory effects.
• Leafy greens and colorful vegetables. Rich in antioxidants and phytonutrients that combat inflammation.
• Berries. Blueberries, strawberries, and raspberries are low-glycemic and high in anti-inflammatory compounds.
• Nuts and seeds. Walnuts, flaxseeds, and chia seeds provide healthy fats and anti-inflammatory properties.
• Extra virgin olive oil. A staple anti-inflammatory fat that can be used for cooking and dressings.
• Turmeric and ginger. Both have well-documented anti-inflammatory properties and can be incorporated into meals and beverages.

Specific micronutrients for PCOS

Women with PCOS often have specific micronutrient needs that should be addressed during treatment. Your PEAK dietitian will assess your individual levels, but common considerations include:

• Inositol. Myo-inositol and D-chiro-inositol have been studied for their role in improving insulin sensitivity and ovarian function in women with PCOS.
• Vitamin D. Deficiency is common in women with PCOS and is associated with worsened insulin resistance. Supplementation may improve metabolic and reproductive outcomes.
• Magnesium. Plays a role in insulin signaling and glucose metabolism. Many women with PCOS are deficient.
• Omega-3 fatty acids. In addition to dietary sources, supplementation may be recommended for anti-inflammatory benefits and improved lipid profiles.
• Folate. Particularly important if pregnancy is a possibility, as adequate folate is critical during early pregnancy for neural tube development.

Boxed warning — thyroid C-cell tumors: GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) carry an FDA boxed warning for thyroid C-cell tumors observed in rodent studies. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Tell your provider immediately if you notice a lump in your neck, difficulty swallowing, or persistent hoarseness.

Medication labeling reminder: Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes only. For weight management, the FDA-approved options are Wegovy (semaglutide) and Zepbound (tirzepatide).

The PEAK Clinical Team

PEAK Wellness & Aesthetics

Evidence-based guidance from our board-certified clinicians specializing in medical weight loss and obesity medicine.